Transcystic Versus Transanastomotic Tube Drainage in Right Lobe LDLT

Sponsor
Mansoura University (Other)
Overall Status
Unknown status
CT.gov ID
NCT01907750
Collaborator
(none)
180
1
2
89
2

Study Details

Study Description

Brief Summary

To evaluate the safety and effectiveness of the use of transcystic biliary drainage tube (not transanastomotic) in comparison to the usual transanastomotic biliary drainage tube.

Condition or Disease Intervention/Treatment Phase
  • Device: biliary drainage tube
Phase 3

Detailed Description

a biliary drainage tube is usually inserted into the biliary passage after choledocho-choledochostomy (bile duct to bile duct joining).

A 4F or 5F biliary catheter (Marquat Genie biomedical, france) is used in all cases.

the study is to compare the effectiveness and safety of 2 different placement techniques:

  1. the usual trans-anastomotic position (the tube is placed across the anastomosis line with the tip inside the intrahepatic biliary branches) through an opening in the wall of the recipient's common bile duct

  2. a transcystic non-anastomotic position (the tube is placed through the cystic duct opening into the distal common bile duct not passing through anastomosis)

Study Design

Study Type:
Interventional
Anticipated Enrollment :
180 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
Transcystic Versus Transanastomotic Biliary Drainage Tubes in Living Donor Liver Transplantation. A Prospective Randomized Trial.
Study Start Date :
Jan 1, 2009
Anticipated Primary Completion Date :
Mar 1, 2016
Anticipated Study Completion Date :
Jun 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Transanastomotic tube

use of transanastomotic tube.

Device: biliary drainage tube

Active Comparator: Transcystic tube

use of transcystic tube to drain bile duct

Device: biliary drainage tube

Outcome Measures

Primary Outcome Measures

  1. early postoperative biliary fistula [2 weeks]

Secondary Outcome Measures

  1. biliary stricture [2 years postoperatively]

Eligibility Criteria

Criteria

Ages Eligible for Study:
2 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • living donor liver transplantation

  • single bile duct in the graft

Exclusion Criteria:
  • multiple bile ducts

Contacts and Locations

Locations

Site City State Country Postal Code
1 Gastro-enterolgy surgical center, Mansoura University Mansoura Al-Dakahleia Egypt 35516

Sponsors and Collaborators

  • Mansoura University

Investigators

  • Principal Investigator: Ahmad M Sultan, MD, PhD, Gastro-enterology surgical center, Mansoura University
  • Study Chair: Mohammed Abdul-Wahab, MD, PhD, Gastro-enterolgy surgical center, Mansoura University
  • Study Director: Tarek Salah, MD, PhD, Gastro-enterolgy surgical center, Mansoura University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ahmad Mohammad Ahmad Sultan, Assistant professor, Mansoura University
ClinicalTrials.gov Identifier:
NCT01907750
Other Study ID Numbers:
  • Biliary_TCvsTA
First Posted:
Jul 25, 2013
Last Update Posted:
Mar 1, 2016
Last Verified:
Feb 1, 2016
Keywords provided by Ahmad Mohammad Ahmad Sultan, Assistant professor, Mansoura University

Study Results

No Results Posted as of Mar 1, 2016